-
Mashup Score: 0Development of Oncology Fellowship Providing Specialized Education for Newly Registered Nurses - 15 hour(s) ago
At the 2025 ONS Congress, Nicole Ferreira, MSN, RN, NPD-BC, BMTCN, OCN shares the development of an oncology fellowship program aimed to improve specialized practitioner education and competence as well as decrease practice turnover.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 0FDA Grants Accelerated Approval to Dordaviprone for Patients With Diffuse Midline Glioma - 15 hour(s) ago
The FDA has granted accelerated approval for dordaviprone for the treatment of patients with diffuse midline glioma.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet-
The @US_FDA granted accelerated approval to the protease activator #dordaviprone for the treatment of adult and pediatric patients with diffuse midline #glioma with an #H3K27M mutation and progressive disease after previous therapy. Learn more: https://t.co/YsQpCClAJ7 https://t.co/HDFHRNWEWG
-
-
Mashup Score: 10Volume 37 - Issue 8 - August, 2025 - 18 hour(s) ago
Publication: Journal of Invasive Cardiology Issue: Volume 37 – Issue 8 – August, 2025 Created: Wed, 08/06/2025 – 10:30 Volume 37 Issue 8
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet-
📖 Read the August issue now! https://t.co/KHKY72dR6U @CCAD_MHIF @esbrilakis @m1chaella_alex @Dr_JHAnderson @tulliopalmerini @DrDamluji @DLBHATTMD #cardioTwitter #cardioX #cardiology #interventionalcardiology https://t.co/oBkYHt8zt1
-
-
Mashup Score: 0
Maryanne Makredes Senna, MD, introduces the clinical fundamentals of alopecia areata, including its immunologic underpinnings, diagnostic challenges, and association with other medical conditions. Dr Senna demystifies the disease’s unpredictable course and highlights the significant psychological burden it places on patients.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, DermatologyTweet-
🎧 PODCAST: Alopecia areata isn't just hair loss. Dr Maryanne Senna covers diagnosis, immune triggers & emotional toll in Part 1 of The Reality of AA. Listen → https://t.co/VUpRwoWySO #AlopeciaAreata #HairLossAwareness #Autoimmune #DermPodcast #Dermatology
-
-
Mashup Score: 0Second-Line Trastuzumab Deruxtecan for Patients With HER2-Positive Gastric/Gastroesophageal Junction Adenocarcinoma - 20 hour(s) ago
According to results from the phase 3 DESTINY-Gastric04 trial, trastuzumab deruxtecan in the second line significantly improved outcomes compared to ramucirumab plus paclitaxel among patients with HER2-positive unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet-
Trastuzumab deruxtecan in the second line significantly improved outcomes compared to ramucirumab plus paclitaxel among patients with HER2-positive unresectable or metastatic G/GEJ adenocarcinoma. Learn more: https://t.co/L5ZZV0jXjV #medtwitter #onctwitter https://t.co/NIOOHVkL49
-
-
Mashup Score: 0
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet-
The Role of Bioresorbable Stents in Tibial Disease: When and Where? Dr Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons (DCBs) in treating infrapopliteal arterial disease. https://t.co/oKR2tuG1fb https://t.co/TLfRPN1pWh
-
-
Mashup Score: 0Exploring Patient-Directed Care and Treatment Options for Patients With Myelodysplastic Syndromes - 2 day(s) ago
At the 2025 Great Debates in Hematologic Malignancies meeting, Aditi Shastri, MD, discussed evolving treatment options and strategies for patients with MDS.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet-
At the 2025 Great Debates in Hematologic Malignancies meeting, Aditi Shastri, MD, discussed evolving treatment options and #strategies for patients with #MDS. Learn more: https://t.co/rKyVjPlfNt https://t.co/7Bf3PXv86U
-
-
Mashup Score: 4Volume 33 - Issue 5 - July/August 2025 - 2 day(s) ago
Publication: The Dermatologist Issue: Volume 33 – Issue 5 – July/August 2025 Created: Fri, 08/01/2025 – 11:54 Volume 33 Issue 5
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, DermatologyTweet-
📢 Exciting News! 🎉 Our July/August 2025 Issue is out now! Explore the latest research, insights, and advancements in the field of dermatology. Stay informed with our comprehensive coverage. https://t.co/btdH2H9suz #Derm #Dermatology #Dermatologist #DermTwitter
-
-
Mashup Score: 18Stentless Revascularization of Spontaneous Coronary Dissection Using a Cutting Balloon - 2 day(s) ago
A 37-year-old woman with no prior medical history was admitted with a non-ST-segment elevation myocardial infarction. Despite initial medical therapy, she developed refractory chest pain, T-wave inversion in the precordial leads, and anterior wall akinesia on echocardiography.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet-
🆕in Early View: Stentless Revascularization of Spontaneous Coronary Dissection Using a Cutting Balloon https://t.co/D2HzohHhF8 @NoReflow @DLBHATTMD #cardioTwitter #cardioX #cardiology #interventionalcardiology https://t.co/v6Zv6cUqtn
-
-
Mashup Score: 0Palbociclib Monotherapy Demonstrates Modest Clinical Activity Among Patients With Locally Advanced or Metastatic Chordoma - 2 day(s) ago
According to final results from the NCT PMO-1601 trial, palbociclib monotherapy demonstrated modest clinical activity among patients with locally advanced or metastatic chordoma.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet-
According to final results from the #NCTPMO1601 trial, #palbociclib monotherapy demonstrated modest clinical activity among patients with locally advanced or metastatic #chordoma. Learn more: https://t.co/2IVs5IFhIw #medtwitter #onctwitter https://t.co/4xShTKCzkr
-
At the 2025 ONS Congress, Nicole Ferreira, MSN, RN, NPD-BC, BMTCN, OCN shares the development of an oncology fellowship program aimed to improve specialized practitioner education and competence as well as decrease practice turnover. Learn more: https://t.co/uEE3Llhuba https://t.co/2IwGFg9uXL